BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3470579)

  • 1. Effect of platelet-derived growth factor on enriched populations of haemopoietic progenitors from patients with chronic myeloid leukaemia.
    Katz FE; Michalevicz R; Lam G; Hoffbrand AV; Goldman JM
    Leuk Res; 1987; 11(4):339-44. PubMed ID: 3470579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor stimulates growth of highly enriched multipotent haemopoietic progenitors.
    Michalevicz R; Katz F; Stroobant P; Janossy G; Tindle RW; Hoffbrand AV
    Br J Haematol; 1986 Jul; 63(3):591-8. PubMed ID: 3488072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-ordinate expression of BI.3C5 and HLA-DR antigens on haemopoietic progenitors from chronic myeloid leukaemia.
    Katz FE; Watt SM; Martin H; Lam G; Capellaro D; Goldman JM; Greaves MF
    Leuk Res; 1986; 10(8):961-71. PubMed ID: 3462439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of platelet-derived growth factor on human pluripotent progenitor (CFU-GEMM) growth in vitro.
    Michalevicz R; Francis GE; Price GM; Hoffbrand AV
    Leuk Res; 1985; 9(3):399-405. PubMed ID: 3858610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells.
    Delwiche F; Raines E; Powell J; Ross R; Adamson J
    J Clin Invest; 1985 Jul; 76(1):137-42. PubMed ID: 4019772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of haemopoietic progenitor cells from patients with chronic granulocytic leukaemia using percoll density gradients and elutriation.
    Martin H; Hibbin JA; Dowding C; Matutes E; Tindle R; Goldman JM
    Br J Haematol; 1986 May; 63(1):187-98. PubMed ID: 3011059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
    Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W
    Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
    Plasilova M; Zivny J; Jelinek J; Neuwirtova R; Cermak J; Necas E; Andera L; Stopka T
    Leukemia; 2002 Jan; 16(1):67-73. PubMed ID: 11840265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody that inhibits the action of GM-CSF on normal but not leukaemic progenitors.
    Ashman LK; Cambareri AC; Eglinton JM
    Leuk Res; 1990; 14(7):637-44. PubMed ID: 1697006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia.
    Januszewicz E; Rabizadah E; Maimon Z; Zaizov R; Shaklai M
    Pathology; 1988 Jan; 20(1):1-6. PubMed ID: 3163796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interleukin 2 and anti-Tac influence the growth of enriched multipotent hemopoietic progenitors: proposed hypotheses for different responses in early and late progenitors.
    Michalevicz R; Campana D; Katz FE; Janossy G; Hoffbrand AV
    Leuk Res; 1988; 12(2):113-21. PubMed ID: 3128693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukaemia (CML). I. Persistence of Ph1-negative committed progenitors that are suppressed from differentiating in vivo.
    Dubé ID; Gupta CM; Kalousek DK; Eaves CJ; Eaves AC
    Br J Haematol; 1984 Apr; 56(4):633-44. PubMed ID: 6585219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
    Ratajczak MZ; Ratajczak J; Machalinski B; Majka M; Marlicz W; Carter A; Pietrzkowski Z; Gewirtz AM
    Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
    Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.